Comparison

Exenatide vs. Pramlintid

Two peptides side-by-side — identity, evidence base, legal status and known adverse events.

Identity

Mechanism of action

Exenatide

Exenatide is a 39-amino-acid peptide with about 53% sequence homology to human GLP-1. A glycine substitution at position 2 prevents dipeptidyl-peptidase-IV cleavage and extends the half-life from native GLP-1 (minutes) to about 2.4 hours. GLP-1 receptor activation glucose-dependently stimulates insulin secretion, inhibits glucagon and delays gastric emptying.

Pramlintid

Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.

Evidence base

Highest evidence

Human RCT

Studies

of which in humans

Effects recorded

Open conflicts

Documented adverse events

Legal status

Country	Exenatide	Pramlintid
Germany	Prescription	Unapproved
United States	Prescription	Prescription

Full entries

Frequently asked questions

What is the difference between Exenatide and Pramlintid?: Exenatide is classified as "Metabolic", while Pramlintid is classified as "Metabolic". Exenatide: Synthetic version of exendin-4, originally isolated from the saliva of the Gila monster (Heloderma suspectum). First GLP-1 receptor agonist, FDA-approved 2005 as Byetta. Weekly depot form Bydureon approved 2012. Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Exenatide or Pramlintid?: The highest available evidence level is "Human RCT" for Exenatide and "Human RCT" for Pramlintid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Exenatide and Pramlintid in Germany and the United States?: Germany: Exenatide — Prescription, Pramlintid — Unapproved. United States: Exenatide — Prescription, Pramlintid — Prescription. These are factual summaries with source and review date on the individual pages.

Country

Exenatide

Pramlintid

Germany

Prescription

Unapproved

United States

Prescription

Frequently asked questions

What is the difference between Exenatide and Pramlintid?

Exenatide is classified as "Metabolic", while Pramlintid is classified as "Metabolic". Exenatide: Synthetic version of exendin-4, originally isolated from the saliva of the Gila monster (Heloderma suspectum). First GLP-1 receptor agonist, FDA-approved 2005 as Byetta. Weekly depot form Bydureon approved 2012. Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Exenatide or Pramlintid?

The highest available evidence level is "Human RCT" for Exenatide and "Human RCT" for Pramlintid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Exenatide and Pramlintid in Germany and the United States?

Germany: Exenatide — Prescription, Pramlintid — Unapproved. United States: Exenatide — Prescription, Pramlintid — Prescription. These are factual summaries with source and review date on the individual pages.